Sort   by:  
 Page size 
UnknownContinuing single-agent bevacizumab as maintenance therapy after induction XELOX (or FOLFOX) plus bevacizumab in first-line treatment of metastatic colorectal cancer.
Not available
S-EPMC3500363 | biostudies-literature
UnknownUpdated Integrated Analysis of the Efficacy and Safety of Entrectinib in Patients With NTRK Fusion-Positive Solid Tumors.
Not available
S-EPMC9365368 | biostudies-literature
UnknownSynthesis of Triazole-Linked SAM-Adenosine Conjugates: Functionalization of Adenosine at N-1 or N-6 Position without Protecting Groups.
Not available
S-EPMC7397255 | biostudies-literature
UnknownHeterozygous <i>RPA2</i> variant as a novel genetic cause of telomere biology disorders.
Not available
S-EPMC11444173 | biostudies-literature
UnknownIncreased Sirt1 secreted from visceral white adipose tissue is associated with improved glucose tolerance in obese Nrf2-deficient mice.
Not available
S-EPMC7721645 | biostudies-literature
UnknownFirst line treatment of metastatic renal cell carcinoma: two standards with different toxicity profile.
Not available
S-EPMC3938518 | biostudies-literature
UnknownDevelopment of a real-time flexible multiphoton microendoscope for label-free imaging in a live animal.
Not available
S-EPMC4682136 | biostudies-literature
UnknownPanitumumab-based maintenance after oxaliplatin discontinuation in metastatic colorectal cancer: A retrospective analysis of two randomised trials.
Not available
S-EPMC6590196 | biostudies-literature
UnknownCheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer.
Not available
S-EPMC6161834 | biostudies-literature
UnknownIdentification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance.
Not available
S-EPMC2000539 | biostudies-literature
Sort   by:  
 Page size